Literature DB >> 12351696

Characterization of a novel and functional human prolactin receptor isoform (deltaS1PRLr) containing only one extracellular fibronectin-like domain.

J Bradford Kline1, Michael A Rycyzyn, Charles V Clevenger.   

Abstract

Prolactin (PRL)-dependent signaling occurs as the result of ligand-induced homodimerization of the PRL receptor (PRLr). To date, short, intermediate, and long human PRLr isoforms have been characterized. To investigate the expression of other possible human PRLr isoforms, RT-PCR was performed on mRNA isolated from the breast carcinoma cell line T47D. A 1.5-kb PCR fragment was isolated, subcloned, and sequenced. The PCR product exhibited a nucleotide sequence 100% homologous to the human long isoform except bp 71-373 were deleted, which code for the S1 motif of the extracellular domain. Therefore, this isoform was designated the deltaS1 PRLr. Northern analysis revealed variable deltaS1 PRLr mRNA expression in a variety of tissues. Transfection of Chinese hamster ovary cells with deltaS1 cDNA showed the isoform is expressed at the protein level on the cell surface with a molecular mass of approximately 70 kDa. Kinetic studies indicated the deltaS1 isoform bound ligand at a lower affinity than wild-type receptor. The deltaS1 PRLr was also shown to activate the proximal signaling molecule Jak2 upon addition of ligand to transfected cells, and, unlike the long PRLr, high concentrations of ligand did not function as a self-antagonist to signaling during intervals of PRL serum elevation, i.e. stress and pregnancy. Given its apparent widespread expression, this PRLr isoform may contribute to PRL action. Furthermore, the functionality of this receptor raises interesting questions regarding the minimal extracellular domain necessary for ligand-induced receptor signaling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12351696     DOI: 10.1210/me.2001-0033

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  15 in total

1.  Development of a prolactin receptor-targeting fusion toxin using a prolactin antagonist and a recombinant form of Pseudomonas exotoxin A.

Authors:  John F Langenheim; Wen Y Chen
Journal:  Breast Cancer Res Treat       Date:  2005-04       Impact factor: 4.872

2.  New homologous bioassays for human lactogens show that agonism or antagonism of various analogs is a function of assay sensitivity.

Authors:  Sophie Bernichtein; Sébastien Jeay; Roland Vaudry; Paul A Kelly; Vincent Goffin
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

Review 3.  The role of prolactin in mammary carcinoma.

Authors:  Charles V Clevenger; Priscilla A Furth; Susan E Hankinson; Linda A Schuler
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

4.  Structure and function of a new class of human prolactin antagonists.

Authors:  Laura DePalatis; Colleen M Almgren; Jypji Patmastan; Mark Troyer; Todd Woodrich; Charles L Brooks
Journal:  Protein Expr Purif       Date:  2009-02-21       Impact factor: 1.650

5.  Negative regulation of prolactin receptor stability and signaling mediated by SCF(beta-TrCP) E3 ubiquitin ligase.

Authors:  Ying Li; K G Kuresh Kumar; Weigang Tang; Vladimir S Spiegelman; Serge Y Fuchs
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

Review 6.  Regulation of prolactin receptor levels and activity in breast cancer.

Authors:  G Swaminathan; B Varghese; S Y Fuchs
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-19       Impact factor: 2.673

7.  Characterization of Δ7/11, a functional prolactin-binding protein.

Authors:  J M Fleming; E Ginsburg; C W McAndrew; C D Heger; L Cheston; J Rodriguez-Canales; B K Vonderhaar; P Goldsmith
Journal:  J Mol Endocrinol       Date:  2012-12-31       Impact factor: 5.098

8.  S2 deletion variants of human PRL receptors demonstrate that extracellular domain conformation can alter conformation of the intracellular signaling domain.

Authors:  Dunyong Tan; Kuang Tzu Huang; Eric Ueda; Ameae M Walker
Journal:  Biochemistry       Date:  2007-12-15       Impact factor: 3.162

9.  Prolactin receptor expression and breast cancer: relationships with tumor characteristics among pre- and post-menopausal women in a population-based case-control study from Poland.

Authors:  Jessica M Faupel-Badger; Maire A Duggan; Mark E Sherman; Montserrat Garcia-Closas; Xiaohong R Yang; Jolanta Lissowska; Louise A Brinton; Beata Peplonska; Barbara K Vonderhaar; Jonine D Figueroa
Journal:  Horm Cancer       Date:  2013-11-19       Impact factor: 3.869

Review 10.  Molecular mechanisms of prolactin and its receptor.

Authors:  Charles L Brooks
Journal:  Endocr Rev       Date:  2012-05-10       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.